Paul Modlinger

792 total citations
9 papers, 653 citations indexed

About

Paul Modlinger is a scholar working on Biochemistry, Cardiology and Cardiovascular Medicine and Physiology. According to data from OpenAlex, Paul Modlinger has authored 9 papers receiving a total of 653 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Biochemistry, 4 papers in Cardiology and Cardiovascular Medicine and 4 papers in Physiology. Recurrent topics in Paul Modlinger's work include Eicosanoids and Hypertension Pharmacology (5 papers), Nitric Oxide and Endothelin Effects (4 papers) and Renin-Angiotensin System Studies (3 papers). Paul Modlinger is often cited by papers focused on Eicosanoids and Hypertension Pharmacology (5 papers), Nitric Oxide and Endothelin Effects (4 papers) and Renin-Angiotensin System Studies (3 papers). Paul Modlinger collaborates with scholars based in United States, Japan and United Kingdom. Paul Modlinger's co-authors include Christopher S. Wilcox, Shakil Aslam, William J. Welch, Margarida Mendonca, Tinatin Chabrashvili, Kathy K. Griendling, Yifan Chen, Anton Wellstein, David G. Harrison and Noritaka Kawada and has published in prestigious journals such as Gastroenterology, Circulation Research and Hypertension.

In The Last Decade

Paul Modlinger

9 papers receiving 637 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul Modlinger United States 8 251 211 135 129 91 9 653
Hiroto Matsuda Japan 14 162 0.6× 257 1.2× 134 1.0× 74 0.6× 170 1.9× 35 589
M. A. Boim Brazil 9 127 0.5× 354 1.7× 151 1.1× 103 0.8× 103 1.1× 15 755
Yale Huang Italy 8 285 1.1× 450 2.1× 111 0.8× 88 0.7× 63 0.7× 8 807
Pamela J. Shultz United States 11 328 1.3× 261 1.2× 86 0.6× 88 0.7× 89 1.0× 14 606
Pablo Forte United Kingdom 12 385 1.5× 316 1.5× 91 0.7× 88 0.7× 49 0.5× 25 827
Francisca Rodríguez Spain 15 157 0.6× 166 0.8× 256 1.9× 149 1.2× 69 0.8× 31 738
Sohachi Fujimoto Japan 13 163 0.6× 163 0.8× 181 1.3× 62 0.5× 207 2.3× 18 747
Darcy M. Richardson United States 10 315 1.3× 207 1.0× 163 1.2× 73 0.6× 43 0.5× 14 747
Shigeru Yagi Japan 15 252 1.0× 387 1.8× 111 0.8× 63 0.5× 102 1.1× 65 715
C Lechi Italy 16 151 0.6× 231 1.1× 122 0.9× 91 0.7× 45 0.5× 45 657

Countries citing papers authored by Paul Modlinger

Since Specialization
Citations

This map shows the geographic impact of Paul Modlinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Modlinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Modlinger more than expected).

Fields of papers citing papers by Paul Modlinger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Modlinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Modlinger. The network helps show where Paul Modlinger may publish in the future.

Co-authorship network of co-authors of Paul Modlinger

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Modlinger. A scholar is included among the top collaborators of Paul Modlinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Modlinger. Paul Modlinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Welch, William J., Paul Modlinger, Margarida Mendonca, et al.. (2007). Roles of vasoconstrictor prostaglandins, COX-1 and -2, and AT1, AT2, and TP receptors in a rat model of early 2K,1C hypertension. American Journal of Physiology-Heart and Circulatory Physiology. 293(5). H2644–H2649. 26 indexed citations
2.
Wang, Dan, Pritmohinder S. Gill, Tinatin Chabrashvili, et al.. (2007). Isoform-Specific Regulation by N G , N G -Dimethylarginine Dimethylaminohydrolase of Rat Serum Asymmetric Dimethylarginine and Vascular Endothelium-Derived Relaxing Factor/NO. Circulation Research. 101(6). 627–635. 113 indexed citations
3.
Modlinger, Paul, Tinatin Chabrashvili, Margarida Mendonca, et al.. (2006). RNA Silencing In Vivo Reveals Role of p22 phox in Rat Angiotensin Slow Pressor Response. Hypertension. 47(2). 238–244. 115 indexed citations
4.
Kawada, Noritaka, Glenn Solis, Paul Modlinger, et al.. (2005). Cyclooxygenase-1–Deficient Mice Have High Sleep-to-Wake Blood Pressure Ratios and Renal Vasoconstriction. Hypertension. 45(6). 1131–1138. 28 indexed citations
5.
Kawada, Noritaka, Glenn Solis, Paul Modlinger, et al.. (2004). TP receptors regulate renal hemodynamics during angiotensin II slow pressor response. American Journal of Physiology-Renal Physiology. 287(4). F753–F759. 51 indexed citations
6.
Modlinger, Paul, Christopher S. Wilcox, & Shakil Aslam. (2004). Nitric oxide, oxidative stress, and progression of chronic renal failure. Seminars in Nephrology. 24(4). 354–365. 235 indexed citations
7.
Modlinger, Paul & William J. Welch. (2003). Adenosine A1 receptor antagonists and the kidney. Current Opinion in Nephrology & Hypertension. 12(5). 497–502. 60 indexed citations
8.
Sharma, Virender K., Sri Komanduri, Paul Modlinger, et al.. (2001). An Audit of The Utility of in-Patient Fecal Occult Blood Testing. The American Journal of Gastroenterology. 96(4). 1256–1260. 23 indexed citations
9.
Sharma, Virender K., Paul Modlinger, David C. Metz, et al.. (2000). Misuse of in-patient fecal occult blood testing (FOBT): Results of an audit. Gastroenterology. 118(4). A268–A268. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hiroto Matsuda Breakdown of academic impact, for papers by M. A. Boim Breakdown of academic impact, for papers by Yale Huang Breakdown of academic impact, for papers by Pamela J. Shultz Breakdown of academic impact, for papers by Pablo Forte Breakdown of academic impact, for papers by Francisca Rodríguez Breakdown of academic impact, for papers by Sohachi Fujimoto Breakdown of academic impact, for papers by Darcy M. Richardson Breakdown of academic impact, for papers by Shigeru Yagi Breakdown of academic impact, for papers by C Lechi
Rankless by CCL
2026